Comparison of the roche cobas® 4800 HPV assay to roche amplicor for detection of high-risk human papillomavirus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 8, 2016, Pages 1305-1307

  Phillips, S ^a,b,c   Cornall, A M ^a,c   Machalek, D A ^a,c   Garland, S M ^a,c,d   Bateson, D ^e   Garefalakis, M ^f   Tabrizi, S N ^a,c,d  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Family Planning New South Wales   (Australia)

^f Family Planning Western Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 52; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS; YOUNG ADULT; ADOLESCENT; COMPARATIVE STUDY; DIAGNOSTIC KIT; GENETICS; NUCLEIC ACID AMPLIFICATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; REPRODUCIBILITY; STANDARDS; VIROLOGY;

DIAGNOSTIC KIT;

ADOLESCENT; ADULT; FEMALE; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 85027941649     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2665-1     Document Type: Article

References (9)

1. Tabrizi SN et al (2014) Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis 14(10): 958–66
2. Phillips S et al (2015) Comparison of the Roche Cobas((R)) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Ampl i cor for Det ect i on of Hi gh-Ri sk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia. J Clin Virol 62:63–5
3. Nygard M et al (2014) Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme. BMJ Open 4(1), e003460
4. Tabrizi SN et al (2012) Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears. J Clin Microbiol 50(8):2796–8
5. Stoler MH et al (2012) The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study. Am J Clin Pathol 137(2):295–303
6. Wright, T.C., Jr., et al. (2012) The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 206(1): p. 46.e1-46.e11
7. Mackinnon A (2000) A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med 30(3):127–34
8. Stevens MP et al (2007) Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 45(7):2130–7
9. Gage JC et al (2012) Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests. J Clin Microbiol 50(1):61–5